Sysmex Corporation (SSMXF)

Market Cap	8.15B +18.2%
Revenue (ttm)	3.23B +4.5%
Net Income	243.59M -16.1%
EPS	0.40 -15.7%
Shares Out	n/a
PE Ratio	28.12
Forward PE	n/a
Dividend	0.25 (2.17%)
Ex-Dividend Date	Sep 29, 2026

Volume	950
Open	11.35
Previous Close	12.04
Day's Range	11.35 - 12.03
52-Week Range	7.97 - 12.50
Beta	0.68
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers hematology, a major test routinely included in blood tests; Flow Cytometry (FCM) analyzes cell properties by irradiating individual cells with a laser and measuring the intensity of light scattering and fluorescence; urinalysis test checks for the presence of glucose, proteins, and blood in urine; clinical chemistry; hemostasis; immunochemistry; cancer gene testing; and antimicrobial susceptibility testing. T...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1968
• Employees: 10,861
• Stock Exchange: OTCMKTS
• Ticker Symbol: SSMXF

Financial Performance

In fiscal year 2026, Sysmex's revenue was 500.01 billion, a decrease of -1.70% compared to the previous year's 508.64 billion. Earnings were 35.46 billion, a decrease of -33.93%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 10, 2026

Data Sources Report a data error